Imaxio's Unattributed VC Round

Imaxio raised a round of funding on June 16, 2009.

Imaxio is an integrated biotech company focused on vaccines and genomics, and based on the combination of R&D and commercial activities: MX313: a technology platform using recombinant carrier protein…

Articles about Imaxio's Unattributed VC Round: